Hepatocellular Carcinoma Research

2 researchers across 2 institutions

2 Researchers
2 Institutions
0 Grant PIs
0 High Impact

Hepatocellular carcinoma (HCC) research investigates the molecular mechanisms driving liver cancer development and progression. Studies explore cancer-related molecular mechanisms, focusing on how cellular signaling pathways and protein interactions contribute to tumorigenesis. Researchers employ network medicine analysis and meta-analysis to identify patterns in complex biological data, aiming to uncover potential therapeutic targets. This work also examines the role of extracellular vesicles in disease pathogenesis and explores the potential of traditional Chinese medicine in cancer treatment.

Given the prevalence of certain risk factors for liver disease in Arkansas, such as obesity and viral hepatitis, research into HCC is particularly relevant to the state's public health. Understanding the underlying causes and identifying effective treatment strategies for liver cancer can directly inform public health initiatives and improve patient outcomes within Arkansas.

This research area benefits from interdisciplinary collaboration, connecting with studies in cancer treatment and pharmacology, lung diseases, and protein interaction mapping. Engagement across Arkansas higher education institutions ensures a broad approach to tackling this complex disease.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Jini Song Arkansas State University 3 25
Timothy Spiva Ouachita Baptist University 1 10

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
12,754 works in 2025
+5.0% CAGR 2018–2025
Leadership concentration
6.0% held by global top 5 institutions
Fragmented HHI 30
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 2,550
  2. 2 Memorial Sloan Kettering Cancer Center 2,243
  3. 3 Harvard University 1,623
  4. 4 Massachusetts General Hospital 1,432
  5. 5 Johns Hopkins University 1,346
Browse All 2 Researchers in Directory